Ascendis Pharma A (ASND) Non-Current Receivables (2016 - 2025)
Historic Non-Current Receivables for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to $11.2 million.
- Ascendis Pharma A's Non-Current Receivables fell 3316.79% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 3316.79%. This contributed to the annual value of $10.2 million for FY2024, which is 5056.39% down from last year.
- According to the latest figures from Q3 2025, Ascendis Pharma A's Non-Current Receivables is $11.2 million, which was down 3316.79% from $9.1 million recorded in Q2 2025.
- In the past 5 years, Ascendis Pharma A's Non-Current Receivables ranged from a high of $32.0 million in Q2 2024 and a low of $8.7 million during Q1 2021
- In the last 5 years, Ascendis Pharma A's Non-Current Receivables had a median value of $16.1 million in 2022 and averaged $17.1 million.
- In the last 5 years, Ascendis Pharma A's Non-Current Receivables soared by 35338.98% in 2021 and then plummeted by 7156.37% in 2025.
- Quarter analysis of 5 years shows Ascendis Pharma A's Non-Current Receivables stood at $23.0 million in 2021, then crashed by 43.04% to $13.1 million in 2022, then skyrocketed by 56.93% to $20.5 million in 2023, then tumbled by 51.19% to $10.0 million in 2024, then increased by 11.67% to $11.2 million in 2025.
- Its last three reported values are $11.2 million in Q3 2025, $9.1 million for Q2 2025, and $9.0 million during Q1 2025.